The anti-RhD monoclonal antibody binds to the surface of red blood cells (RBC) of RhD positive individuals to identify these cells, allowing the quantitation of Ftomaternal hemorrhage (FMH). which may occur during pregnancy or at delivery and lead to immunisation to the D antigen if the mother is D negative and the baby D positive.
